Sulzer aims to take the wear out of joints:
This article was originally published in Clinica
Executive Summary
Swiss company Sulzer Orthopaedics has licensed from the Massachusetts Institute of Technology and Massachusetts General Hospital in the US a new ultra low wear material to improve the performance of replacement joints. The deal gives Sulzer worldwide rights to a polyethylene developed in Massachusetts. The new polyethylene material aims to reduce the incidence of osteolysis, the number one cause of hip implant failure where bone is eroded around the implant. The material will be used to line acetabular inserts, cup like metal implants into which the ball shaped femoral head fits.